መነሻ › አኩት ባይፊኖታይፒክ ሊውኬሚያ › North Carolina
በNorth Carolina ለአኩት ባይፊኖታይፒክ ሊውኬሚያ የሚደረጉ ክሊኒካዊ ጥናቶች
ለአኩት ባይፊኖታይፒክ ሊውኬሚያ የሚደረጉ 11 ጥናቶች በNorth Carolina ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በNorth Carolina ውስጥ ያሉ ከተሞች
Official study text (English)
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Duke University Medical Center, Durham
- እና 2 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
365 Days · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06317662A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Duke University Medical Center, Durham
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
30 Days · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT04065399Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- Mission Hospital, Asheville
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- እና 4 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
365 Days – 25 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT03959085The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Mission Hospital, Asheville
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- እና 4 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እስከ እድሜ 22 · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT04726241Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
- Novant Health Presbyterian Hemby Children's Hospital, Charlotte
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ1 እስከ 18 · ሁሉም ጾታዎች · የተሻሻለው በ10 ኦገስ 2026 · NCT06390319Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ13 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT06533579Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
- Novant Health Presbyterian Hemby Children's Hospital, Charlotte
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ ከ1 እስከ 18 · ሁሉም ጾታዎች · የተሻሻለው በ14 ጁላይ 2026 · NCT06289673Registry of Older Patients With Cancer
- Seby B. Jones Cancer Center, Boone
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
- East Carolina University, Greenville
- እና 4 ተጨማሪ
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 65 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁን 2026 · NCT01137825A Study of Revumenib and Mezigdomide in People With Leukemia
- University of North Carolina (Data Collection Only), Chapel Hill
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁን 2026 · NCT07356154Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ18 እስከ 120 · ሁሉም ጾታዎች · የተሻሻለው በ27 ኦክቶ 2025 · NCT01137643Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Carolina-Levine Children's Hospital, Charlotte
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ1 እስከ 21 · ሁሉም ጾታዎች · የተሻሻለው በ6 ዲሴም 2024 · NCT05476770ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።